Combination of amlodipine besylate and olmesartan medoxomil provides greater reduction in blood pressure compared with monotherapy in subjects with and without diabetes

被引：0
|
作者：
Bakris, G. [1 ]
Karki, S. [2 ]
Lee, J. [2 ]
Heyrman, R. [2 ]
机构：
[1] Univ Chicago, Sch Med, Chicago, IL 60637 USA
[2] Daiichi Sankyo Inc, Parsippany, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [1] Combination of amlodipine besylate plus olmesartan medoxomil provides greater reductions in seated diastolic and systolic blood pressure compared with monotherapy in men and women
    Chrysant, S. G.
    Patron, A.
    Karki, S.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S374 - S374
  • [2] Combination of amlodipine besylate and ohnesartan medoxomfl provides greater reduction in blood pressure compared with monotherapy in naive and non-naive subjects
    Oparil, S.
    Sandoval, J.
    Karki, S.
    Lee, J.
    Melino, M.
    JOURNAL OF HYPERTENSION, 2008, 26 : S376 - S376
  • [3] The Combination of amlodipine besylate plus olmesartan medoxomil provides numerically greater reductions in blood pressure compared with component monotherapies in race and ethnic subgroups
    Oparil, S.
    Ramstad, D.
    Melino, M.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S373 - S374
  • [4] Does body mass index influence blood pressure reduction among subjects treated with combination of amlodipine besylate and olmesartan medoxomil versus component monotherapy?
    Bakris, G.
    Eads, S., Jr.
    Karki, S.
    Lee, J.
    Melino, M.
    JOURNAL OF HYPERTENSION, 2008, 26 : S374 - S374
  • [5] Efficacy of the combination of amlodipine besylate plus olmesartan medoxomil compared to monotherapy in controlling blood pressure in patients with mild-to-severe hypertension
    Chrysant, S. G.
    Oparil, S.
    Bakris, G.
    Melino, M.
    Karki, S.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S375 - S375
  • [6] Combination of amlodipine besylate and olmesartan medoxomil significantly reduces blood pressure in patients with hypertension independent of age
    Chrysant, S. G.
    Rhyne, J.
    Melino, M.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S375 - S375
  • [7] The combinati on of amlodipine besylate and olmesartan medoxomil safely reduces blood pressure compared with monotherapy in both patients with stage 1 and stage 2 hypertension
    Oparil, S.
    Herron, J.
    Melino, M.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S375 - S376
  • [8] The long-term effect of amlodipine besylate plus olmesartan medoxomil combination therapy on achieving blood pressure goals in patients with diabetes
    Bakris, G.
    Karki, S.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S190 - S190
  • [9] Onset of antiltypertensive effect in patients with mild to severe hypertension treated with a combination of amlodipine besylate and olmesartan medoxomil compared with component monotherapy and placebo
    Chrysant, S. G.
    Melino, M.
    Karki, S.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S378 - S378
  • [10] Long-term efficacy of amlodipine besylate plus olmesartan medoxomil combination in achieving blood pressure goals in subjects ≥65 years of age
    Chrysant, S.
    Melino, M.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2008, 26 : S374 - S375
12345